MASSARI, ALESSANDRO
 Distribuzione geografica
Continente #
EU - Europa 2.503
NA - Nord America 2.050
AS - Asia 1.824
SA - Sud America 156
AF - Africa 31
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.574
Nazione #
US - Stati Uniti d'America 1.973
GB - Regno Unito 1.161
CN - Cina 597
SG - Singapore 581
IT - Italia 296
DE - Germania 238
SE - Svezia 222
HK - Hong Kong 138
RU - Federazione Russa 112
FR - Francia 102
BR - Brasile 99
VN - Vietnam 98
IN - India 87
BD - Bangladesh 83
TR - Turchia 79
UA - Ucraina 69
NL - Olanda 67
CA - Canada 55
IE - Irlanda 54
FI - Finlandia 52
KR - Corea 40
JP - Giappone 37
DK - Danimarca 33
EU - Europa 29
PL - Polonia 25
CO - Colombia 21
HU - Ungheria 17
ID - Indonesia 14
AR - Argentina 13
MX - Messico 13
ES - Italia 12
IQ - Iraq 11
UZ - Uzbekistan 11
CI - Costa d'Avorio 9
BE - Belgio 8
PK - Pakistan 8
ZA - Sudafrica 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
AU - Australia 4
BO - Bolivia 4
CH - Svizzera 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
RO - Romania 4
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
JO - Giordania 3
MA - Marocco 3
PY - Paraguay 3
TN - Tunisia 3
TW - Taiwan 3
VE - Venezuela 3
AT - Austria 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CL - Cile 2
CZ - Repubblica Ceca 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
LT - Lituania 2
MD - Moldavia 2
NO - Norvegia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
CG - Congo 1
CR - Costa Rica 1
EG - Egitto 1
HN - Honduras 1
HT - Haiti 1
IM - Isola di Man 1
IS - Islanda 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
NP - Nepal 1
OM - Oman 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
QA - Qatar 1
TT - Trinidad e Tobago 1
YE - Yemen 1
Totale 6.602
Città #
Southend 1.093
Singapore 381
Chandler 258
Ashburn 239
Hong Kong 131
Beijing 128
San Jose 100
Milan 93
Ann Arbor 74
Houston 74
Princeton 65
Dallas 61
Wilmington 58
Jacksonville 56
Boardman 54
Dublin 53
Santa Clara 50
Los Angeles 48
Council Bluffs 47
New York 46
Dearborn 45
Nanjing 41
Seattle 39
Bengaluru 38
Munich 38
Somerville 36
Redmond 30
Des Moines 29
Frankfurt am Main 29
Toronto 29
Phoenix 28
Lauterbourg 27
Fairfield 25
Grafing 25
Hanoi 25
Tokyo 25
Helsinki 24
Warsaw 24
Andover 23
Woodbridge 23
Ho Chi Minh City 22
Jinan 22
Serra 22
Bogotá 21
Buffalo 19
Sakarya 19
Shanghai 19
Istanbul 18
Moscow 18
Changsha 17
Redwood City 16
Rome 15
Tianjin 14
Fuzhou 13
Mountain View 13
Guangzhou 12
Shenyang 12
Berlin 11
Columbus 10
Nanchang 10
Ningbo 10
The Dalles 10
Abidjan 9
Bühl 9
Cangzhou 9
Hebei 9
Hefei 9
Wuhan 9
Ahmadabad 8
Amsterdam 8
Brussels 8
Montreal 8
São Paulo 8
Tashkent 8
Turin 8
Turku 8
Boston 7
Fremont 7
Lanzhou 7
Naples 7
Tampa 7
Da Nang 6
Paris 6
Portsmouth 6
Stockholm 6
Chicago 5
Hangzhou 5
Jakarta 5
Pécs 5
Trento 5
Bitonto 4
Brooklyn 4
Cambridge 4
Charlotte 4
Colorado Springs 4
Costa Mesa 4
Debrecen 4
Dong Ket 4
Falls Church 4
Haiphong 4
Totale 4.297
Nome #
Totally laparoscopic, multi-stage, restorative proctocolectomy for inflammatory bowel diseases. A prospective study on safety, efficacy and long-term results 492
The time course of diagnostic delay in inflammatory bowel disease over the last sixty years : An Italian multicentre study 290
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population 270
Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on Th1/Th2 cytokines in inflammatory bowel disease : an in vitro study 263
Isolated ampullary adenoma causing biliary obstruction 261
The PROSit cohort of infliximab biosimilar in IBD : a prolonged follow-up on the effectiveness and safety across Italy 255
Appropriateness and diagnostic yield of colonoscopy in the management of patients with ulcerative colitis : a prospective study in an open access endoscopy service 235
Use of colonoscopy in the management of patients with Crohn's disease: appropriateness and diagnostic yield 235
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : a 5-years follow-up inception cohort study 231
Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alfa treatment 229
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : a 5-years follow-up inception cohort study 222
Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal 213
Free IL-18 in Crohn's disease : is the target suitable for a therapeutic intervention with IL-18 binding protein? Validation of the expression of free IL-18 in sera of active patients 208
Risk of clinical and surgical relapse in CD patients treated with azathioprine or mesalazine after conservative surgery, according to postoperative CRP levels 207
Indications and diagnostic yield of double-balloon enteroscopy in Crohn's disease 206
Maintenance treatment with azathioprine in ulcerative colitis : outcomes after drug withdrawal in patients with sustained remission 206
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis : a real-life experience 196
Colonoscopy surveillance for dysplasia and colorectal cancer in long-standing ulcerative colitis: a cohort Italian study 193
Colonoscopic surveillance for dysplasia and colorectal cancer in long-standing ulcerative colitis : a cohort Italian study 193
Role, efficacy and safety of budesonide multi-matrix in ulcerative colitis in real life: A study in three Italian third-level centres 193
Maintenance treatment with azathioprine in ulcerative colitis : outcomes after drug withdrawal in patients with sustained remission 191
Prospective randomized comparison of three bowel preparations for elective colonoscopy in patients with inflammatory bowel disease 185
Prevalence and clinical significance of sonographic alteration of mesenteric fat in Crohn's disease 184
Clinical and endoscopic outcome after the first corticosteroid course in newly diagnosed ulcerative colitis : mucosal healing as prognostic predictor in a 5-years follow-up inception cohort study 180
Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn's disease 179
Bowel preparation in patients with inflammatory bowel disease 176
The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar 175
Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease : effects of anti-TNFα treatment 168
Anti-tumour necrosis factor α antibodies and circulating lymphocyte phenotypes in inflammatory bowel disease 168
Role, efficacy and safety of budesonide-MMX in ulcerative colitis in real life : a study in a third-level center 166
Anti-TNF-ALFA second-line infliximab therapy in patients affected by Crohn’s disease and ulcerative colitis: who and how recovers remission? 151
Smoker and ex-smoker patients affected by Crohn’s disease: are they so different? 136
Totale 6.857
Categoria #
all - tutte 16.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202155 0 0 0 0 0 0 0 0 0 0 0 55
2021/2022509 67 13 13 32 30 35 40 25 55 85 18 96
2022/2023652 71 91 60 108 56 111 3 36 76 4 29 7
2023/2024297 4 25 14 14 89 42 21 14 9 10 19 36
2024/2025851 22 69 13 106 73 12 14 77 52 95 91 227
2025/20261.843 225 111 147 122 231 136 187 78 165 205 164 72
Totale 6.857